Invention Grant
- Patent Title: Heterocyclic compounds for the inhibition of PASK
-
Application No.: US14438268Application Date: 2013-10-25
-
Publication No.: US09278973B2Publication Date: 2016-03-08
- Inventor: John McCall , Robert C. Kelly , Donna L. Romero
- Applicant: BioEnergenix, LLC
- Applicant Address: US CA San Francisco
- Assignee: BIOENERGENIX LLC
- Current Assignee: BIOENERGENIX LLC
- Current Assignee Address: US CA San Francisco
- Agent Dennis A. Bennett; Brock Levin
- International Application: PCT/US2013/066782 WO 20131025
- International Announcement: WO2014/066743 WO 20140501
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/519 ; C07D487/04
Abstract:
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
Public/Granted literature
- US20150274740A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK Public/Granted day:2015-10-01
Information query
IPC分类:
